FDA Submissions for Interoperable Medical Devices – Comment Period Extended for Draft Guidance

February 24, 2016

Additional information on FDA’s recommendations for interoperable medical devices is available in our blog post entitled “A Closer Look at FDA’s Draft Guidance Regarding Premarket Submissions for Interoperable Medical Devices.”

On January 26, 2016, the FDA published a draft guidance entitledDesign Considerations and Pre-market Submission Recommendations for Interoperable Medical Devices.”  The document provides medical device manufacturers with assistance regarding product design and labeling of interoperable devices.

Interoperable medical devices are two or more devices that exchange data and information in a safe and effective manner. The ability to do this is a growing need within the healthcare industry, which is what drove the FDA to develop this draft guidance.

When the draft guidance was released in late January, the FDA asked interested persons to submit comments and suggestions by March 28, 2016. In response to a number of requests for an extension, on February 23rd, the FDA announced that the comment period will remain open for an additional 30 days. As such, interested persons should submit comments, questions, and/or concerns by April 28, 2016.

Do you manufacture a medical device or any other type of FDA-regulated product? We can help ensure that your product is compliant with all requirements. For additional information on how we can help you, contact us today.

Medical Devices Agency Alerts

February 28, 2019

Draft Guidance: Requesting Nonbinding Feedback After an FDA Inspection of Your Medical Device Establishment

On Tuesday, February 19th, FDA published a draft guidance for medical device makers which identifies a process for companies to request nonbinding feedback on certain FDA Form 483 deficiencies noted...

Read the Full Article
Agency Alerts General Regulatory

April 18, 2016

FDA Reopens Comment Period for Proposed Rule Regarding Regulation of Fixed-Combination Drugs

On December 23, 2015, the FDA announced a proposed rule regarding the regulation of fixed-combination drugs.  In its announcement, FDA proposed that its requirements for prescription...

Read the Full Article
Agency Alerts General Regulatory

August 28, 2015

FDA Extends Comment Period For Its “Request for Quality Metrics” Draft Guidance

Last month, FDA published a draft guidance titled “Request for Quality Metrics,” which outlined the ways in which it intends to collect and use quality metrics. The guidance states that the data will...

Read the Full Article